Your browser doesn't support javascript.
loading
Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach.
Saifi, Omran; Lester, Scott C; Breen, William G; Rule, William G; Lin, Yi; Bennani, N Nora; Rosenthal, Allison; Munoz, Javier; Murthy, Hemant S; Kharfan-Dabaja, Mohamed A; Peterson, Jennifer L; Hoppe, Bradford S.
Affiliation
  • Saifi O; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Lester SC; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Breen WG; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Rule WG; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Lin Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bennani NN; Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Rosenthal A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Munoz J; Division of Hematology, Mayo Clinic, Phoenix, Arizona, USA.
  • Murthy HS; Division of Hematology, Mayo Clinic, Phoenix, Arizona, USA.
  • Kharfan-Dabaja MA; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Peterson JL; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Hoppe BS; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.
Am J Hematol ; 99(1): 124-134, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37950857

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Am J Hematol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Am J Hematol Year: 2024 Document type: Article